There was no significant difference in the proportions of CD8 + T cell scores/Treg scores between the Mut and WT groups of patients, suggesting a balance of immune effective and suppressive cells and that BRAF mutation may not affect overall immune infiltrates in the NSCLC environment. The gene discussed is BRAF; the disease is non-small cell lung carcinoma.